Reduktion af pyreksi eller feber og lindring af inflammation anses for at være vigtige kliniske indikationer, som bør bibeholdes, da de er tilstrækkeligt veldokumenterede.
Reducing of pyrexia or fever and alleviation of inflammation are considered important clinical claims that should be retained as they have been sufficiently well demonstrated.